Detalhe da pesquisa
1.
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
N Engl J Med
; 375(22): 2121-2132, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26900902
2.
Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
AIDS
; 33(10): 1619-1622, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306167
3.
Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial.
J Acquir Immune Defic Syndr
; 79(5): 580-589, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239426
4.
HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
PLoS One
; 12(6): e0178594, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28658251
5.
Long-term follow-up of HIV seroconverters in microbicide trials - rationale, study design, and challenges in MTN-015.
HIV Clin Trials
; 17(5): 204-11, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465646
6.
Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.
PLoS One
; 10(6): e0128857, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061040
7.
Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring.
J Acquir Immune Defic Syndr
; 77(1): e8-e10, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961677